Andres F. Correa, MD, and Marc C. Smaldone, MD, MSHP

Novel PET radiotracers have shown great potential in the early diagnosis and staging of PCa, detection of post-treatment recurrence, and monitoring of metastases not previously possible with current imaging technologies.